Agilent Technologies, Inc. (A) vs Teva Pharmaceutical Industries Limited (TEVA)
A side-by-side comparison of Agilent Technologies, Inc. and Teva Pharmaceutical Industries Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 28, 2026. Differences are shown without an overall score or investment verdict.
A
Agilent Technologies, Inc.
$153.63HealthcareDelayed quote: Aug 28, 2026, 12:20 PM EDT
TEVA
Teva Pharmaceutical Industries Limited
$36.63HealthcareDelayed quote: Aug 28, 2026, 12:20 PM EDT
Total return — A vs TEVA
growth of $100 · dividends reinvested · last 10yA +261.7% (+13.7%/yr)TEVA -23.4% (-2.6%/yr)A compounded faster over this window
A TEVA
A vs TEVA: by the numbers
- •A is the larger company ($43.39B vs $42.66B market cap).
- •A trades at the lower trailing earnings multiple (31.04 vs 62.70 P/E), one valuation lens rather than an overall verdict.
- •A converts more revenue to profit (19.53% vs 4.08% net margin).
- •A grew revenue faster over the past five years (3.72% vs 1.19% CAGR).
- •A pays a dividend (0.64% yield), while TEVA is a former payer with no current dividend run rate.
Metrics side by side
Valuation
| Metric | A | TEVA |
|---|---|---|
| P/E ratio | 31.04 | 62.70 |
| Forward P/E | 26.02 | 18.80 |
| P/S ratio | 6.05 | 2.57 |
| P/B ratio | 6.06 | 5.73 |
| EV / EBITDA | 24.51 | 19.40 |
| FCF yield | 3.22% | 3.03% |
Profitability
| Metric | A | TEVA |
|---|---|---|
| Gross margin | 53.73% | 52.47% |
| Operating margin | 22.23% | 11.45% |
| Net margin | 19.53% | 4.08% |
| ROE | 19.56% | 9.10% |
| ROIC | 11.88% | 6.79% |
Dividends
| Metric | A | TEVA |
|---|---|---|
| Dividend yield | 0.64% | N/A |
| Payout ratio | 22.07% | N/A |
Growth (annualized)
| Metric | A | TEVA |
|---|---|---|
| Revenue CAGR (5Y) | 3.72% | 1.19% |
| EPS CAGR (5Y) | 14.52% | N/A |
| FCF CAGR (5Y) | 2.54% | 14.58% |
| Total return CAGR (5Y) | -1.23% | 32.11% |
Frequently asked
- Which has the lower trailing P/E, A or TEVA?
- A has the lower trailing P/E: A trades at 31.04 and TEVA at 62.70. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, A or TEVA?
- Over the past five years, A grew revenue faster — A at a 3.72% CAGR versus TEVA at 1.19%.
- Does A or TEVA pay a bigger dividend?
- A pays a dividend (0.64% yield), while TEVA is a former payer with no current dividend run rate.
- Is A or TEVA more profitable?
- A runs the higher net margin — A at 19.53% versus TEVA at 4.08%.
- How have A and TEVA total returns compared?
- Over the past 10 years, A delivered 13.67% and TEVA delivered -2.70% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Agilent Technologies P/E ratioTeva Pharmaceutical Industries P/E ratioAgilent Technologies dividend yieldAgilent Technologies ROETeva Pharmaceutical Industries ROEAgilent Technologies operating marginTeva Pharmaceutical Industries operating marginAgilent Technologies revenue growthTeva Pharmaceutical Industries revenue growthAgilent Technologies free cash flowTeva Pharmaceutical Industries free cash flow
Agilent Technologies & Teva Pharmaceutical Industries appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 28, 2026.